window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

chronic liver disease

  • Chronic diseases,Drug Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets

    Ochre Bio has completed the research phase of its collaboration [...]

    November 18, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Chronic diseases,Drug Development,Genomics and sequencing,Precision medicine,Research & Development

    Mursla Bio partners with global pharma to advance biomarker-guided precision medicine in MASH

    Mursla Bio has announced a collaboration with a leading global [...]

    November 13, 2025
  • Drug Development,Global health,Patient Centricity,Research & Development

    Vitamin D shown to reduce liver damage by activating TXNIP gene, study finds

    New study shows how the vitamin D/TXNIP axis modulates ductular [...]

    July 28, 2025
  • Artificial Intelligence,Drug Development

    Ochre Bio founder takes helm as CEO to drive RNA liver therapies towards clinic

    RNA therapeutics biotech Ochre Bio has appointed its founder and [...]

    July 7, 2025
  • Cell & Gene Therapy

    Hydrogel breakthrough could boost liver cell therapy durability, Likarda paper shows

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close
    Categories: Clinical Development, Data Management, Digital Health, Movers & Shakers, Technology and platforms
  • Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3
    Categories: Biotech, Cell & Gene Therapy, Clinical Development, Movers & Shakers, Pharmaceuticals and therapeutics, Rare Diseases
  • SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research
    Categories: Biotech, Drug Development, Oncology, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top